ArticleOncology letters2018

Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia.

Ling Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.